Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer von Li, Yutao, Sharma, Amit, Schmidt-Wolf, Ingo G H

Volltext

Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer von Chen, Peng, Sharma, Amit, Weiher, Hans, Schmidt-Wolf, Ingo G H

Volltext

Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies von Wang, Yulu, Qin, Jiading, Sharma, Amit, Dakal, Tikam Chand, Wang, Jieyu, Pan, Tiantian, Bhushan, Ravi, Chen, Peng, Setiawan, Maria F, Schmidt-Wolf, Ingo G H, Li, Fei

Volltext

Non-viral and hybrid vectors in human gene therapy: an update von Schmidt-Wolf, Gabriele D, Schmidt-Wolf, Ingo G.H

Volltext

State-of-the-art classification and multimodality treatment of malignant thymoma von Koppitz, Hannah, Rockstroh, Jürgen K, Schüller, Heinrich, Standop, Jens, Skowasch, Dirk, Müller-Hermelink, Hans Konrad, Schmidt-Wolf, Ingo G.H

Volltext

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma von Hudes, Gary, Carducci, Michael, Tomczak, Piotr, Dutcher, Janice, Figlin, Robert, Kapoor, Anil, Staroslawska, Elzbieta, Sosman, Jeffrey, McDermott, David, Bodrogi, István, Kovacevic, Zoran, Lesovoy, Vladimir, Schmidt-Wolf, Ingo G.H, Barbarash, Olga, Gokmen, Erhan, O'Toole, Timothy, Lustgarten, Stephanie, Moore, Laurence, Motzer, Robert J

Volltext

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial von SONNEVELD, Pieter, SCHMIDT-WOLF, Ingo G. H, WEISEL, Katja C, WITTEBOL, Shulamiet, BOS, Gerard M. J, STEVENS-KROEF, Marian, SCHEID, Christof, PFREUNDSCHUH, Michael, HOSE, Dirk, JAUCH, Anna, DER VELDE, Helgi Van, RAYMAKERS, Reinier, DER HOLT, Bronno Van, SCHAAFSMA, Martijn R, KERSTEN, Marie-Jose, MARWIJK-KOOY, Marinus Van, DUEHRSEN, Ulrich, LINDEMANN, Walter, WIJERMANS, Pierre W, LOKHORST, Henk M, GOLDSCHMIDT, Hartmut M, EL JARARI, Laila, BERTSCH, Uta, SALWENDER, Hans, ZWEEGMAN, Sonja, VELLENGA, Edo, BROYL, Annemiek, BLAU, Igor W

Volltext

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer von Dehno, Mojgan Naghizadeh, Li, Yutao, Weiher, Hans, Schmidt-Wolf, Ingo G. H.

Volltext

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma von Zhang, Ying, Ettinger, Joerg, Ritter, Manuel, Schmidt-Wolf, Ingo G. H.

Volltext

RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group von GAIDZIK, Verena I, BULLINGER, Lars, SPÄTH, Daniela, KÜNDGEN, Andrea, SCHMIDT-WOLF, Ingo G. H, GOTZE, Katharina, NACHBAUR, David, PFREUNDSCHUH, Michael, HORST, Heinz A, DÖHNER, Hartmut, DÖHNER, Konstanze, SCHLENK, Richard F, ZIMMERMANN, Andreas S, RÖCK, Jürgen, PASCHKA, Peter, CORBACIOGLU, Andrea, KRAUTER, Jürgen, SCHLEGELBERGER, Brigitte, GANSER, Arnold

Volltext

Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase... von Advani, Anjali, Coiffier, Bertrand, Czuczman, Myron S, Dreyling, Martin, Foran, James, Gine, Eva, Gisselbrecht, Christian, Ketterer, Nicolas, Nasta, Sunita, Rohatiner, Ama, Schmidt-Wolf, Ingo G H, Schuler, Martin, Sierra, Jorge, Smith, Mitchell R, Verhoef, Gregor, Winter, Jane N, Boni, Joseph, Vandendries, Erik, Shapiro, Mark, Fayad, Luis

Volltext

Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma von Seidel, Sabine, Pels, Hendrik, Schlömer, Sabine, Kowoll, Annika, Fliessbach, Klaus, Engert, Andreas, Vogt-Schaden, Marlies, Egerer, Gerlinde, Reichmann, Heinz, Schackert, Gabriele, Kroschinsky, Frank, Deckert, Martina, Herrlinger, Ulrich, Klockgether, Thomas, Fimmers, Rolf, Bode, Udo, Schmidt-Wolf, Ingo G.H., Schlegel, Uwe

Volltext

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding von Wu, Xiaolong, Zhang, Ying, Li, Yutao, Schmidt-Wolf, Ingo G. H.

Volltext

PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines von Li, Yutao, Sharma, Amit, Bloemendal, Maurits, Schmidt-Wolf, Roland, Kornek, Miroslaw, Schmidt-Wolf, Ingo

Volltext

Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide von Messina, Calogero S, Weiher, Hans, Schmidt-Wolf, Ingo G H

Volltext

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial von Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G H, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment von Schlegel, Uwe, Schmidt-Wolf, Ingo G.H, Deckert, Martina

Volltext

Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the... von GRÖSCHEL, Stefan, SCHLENK, Richard F, GERMING, Ulrich, SCHMIDT-WOLF, Ingo G. H, BERNA BEVERLOO, H, SCHUURHUIS, Gerrit J, OSSENKOPPELE, Gert J, SCHLEGELBERGER, Brigitte, VERDONCK, Leo F, VELLENGA, Edo, VERHOEF, Gregor, VANDENBERGHE, Peter, ENGELMANN, Jan, PABST, Thomas, BARGETZI, Mario, KRAUTER, Jürgen, GANSER, Arnold, VALK, Peter J. M, LÖWENBERG, Bob, DÖHNER, Konstanze, DÖHNER, Hartmut, DELWEL, Ruud, ROCKOVA, Veronika, TELEANU, Veronica, KÜHN, Michael W. M, EIWEN, Karina, ERPELINCK, Claudia, HAVERMANS, Marije, LÜBBERT, Michael

Volltext

Utilizing ethacrynic acid and ciclopirox olamine in liver cancer von Al-Dali, Ahmad M, Weiher, Hans, Schmidt-Wolf, Ingo G H

Volltext

EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC von Slomka, Artur, Mocan, Tudor, Wang, Bingduo, Nenu, Iuliana, Urban, Sabine K., Gonzalez-Carmona, Maria A., Schmidt-Wolf, Ingo G. H., Lukacs-Kornek, Veronika, Strassburg, Christian P., Sparchez, Zeno, Kornek, Miroslaw

Volltext